Group One Trading’s ClearPoint Neuro CLPT Stock Holding History

Group One Trading’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.47K	Sell	531 -6,842	-93%	-$85.5K	﹤0.01%	6431
2026 Q1	$67.1K	Buy	+7,373	New	+$93.1K	﹤0.01%	5048
2025 Q4	–	Sell	-12,228	Closed	-$227K	–	8233
2025 Q3	$266K	Buy	+12,228	New	+$144K	﹤0.01%	4363
2024 Q1	–	Sell	-6,959	Closed	-$48.6K	–	7147
2023 Q4	$47.3K	Buy	6,959 +5,897	+555%	+$33.4K	﹤0.01%	5103
2023 Q3	$5.32K	Buy	+1,062	New	+$6.32K	﹤0.01%	6670
2022 Q2	–	Sell	-3,077	Closed	-$31.4K	–	7893
2022 Q1	$32K	Sell	3,077 -8,178	-73%	-$74.4K	﹤0.01%	6426
2021 Q4	$126K	Buy	11,255 +132	+1%	+$1.98K	﹤0.01%	5511
2021 Q3	$197K	Sell	11,123 -2,515	-18%	-$47.2K	﹤0.01%	5187
2021 Q2	$260K	Buy	13,638 +13,589	+27,733%	+$263K	﹤0.01%	4938
2021 Q1	$1K	Buy	+49	New	+$1.05K	﹤0.01%	7447

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CFM

Compass Financial Management Tampa, Florida $829M AUM

Group One Trading's CLPT Position: Q2 2026 in Review

Group One Trading reduced its ClearPoint Neuro (CLPT) stake by 93% in Q2 2026, selling an estimated $85.5K and leaving 531 shares worth $9.47K. The position accounts for ﹤0.01% of the portfolio, ranked #6431.

Group One Trading first reported a position in CLPT in Q1 2021 and has held it in 10 quarters since. The position peaked at $266K in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

Group One Trading held 531 shares of ClearPoint Neuro worth $9.47K as of Q2 2026.
Group One Trading sold 6,842 ClearPoint Neuro shares in Q2 2026, an estimated $85.5K.
ClearPoint Neuro made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6431 holding.
Group One Trading first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 10 quarters since.
Group One Trading's ClearPoint Neuro position peaked at $266K in Q3 2025.
129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.